Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
Premature baby dies weeks after mom loses life to brain tumor
Thu, 21 Sep 2017 14:07:00 GMT (MLive.com)
Brain cancer growth halted by absence of protein | News Center ...
Wed, 20 Sep 2017 17:13:09 GMT (Stanford Medical Center Report)
Brain Cancer Research: Duke University therapy attacks brain ...
Wed, 20 Sep 2017 18:08:11 GMT (News & Observer)
'Grey's Anatomy' actress reveals brain tumor diagnosis
Mon, 18 Sep 2017 20:33:04 GMT (CNN)
Study opens new door to potential treatments for highly lethal brain tumors
Thu, 21 Sep 2017 06:01:08 GMT (News)
A look at other children diagnosed with rare brain tumors in Jackson County
Wed, 20 Sep 2017 10:03:08 GMT (The Sun Herald)
Fun Fest raises funds for brain tumor research
Mon, 18 Sep 2017 13:57:00 GMT (Chicago Daily Herald)
Wandering bear on Rincon beach had a brain tumor
Wed, 20 Sep 2017 00:56:53 GMT (KEYT)
Belgium Jewish Museum Attack Suspect Denied Treatment for Brain Tumor, Lawyer Claims
Thu, 21 Sep 2017 15:58:17 GMT (Haaretz)
Kait's Angels fundraiser to benefit 8-year-old girl with brain tumor
Thu, 21 Sep 2017 14:51:48 GMT (Suffolk Times)
9/21/2017 11:40:22 AM
Feed cached:9/21/2017 12:49:40 PM

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
  
 
Dani Saleh Brain Cancer Research Fund at UCLA


The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.



Persistent diffusion-restricted lesions in bevacizumab-treated malignant gliomas are associated with improved survival compared with matched controls.
AJNR Am J Neuroradiol


Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma.
AJNR Am J Neuroradiol


Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies.
Neuropathol Appl Neurobiol


Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival.
AJNR Am J Neuroradiol


Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
J Magn Reson Imaging



All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2017 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2017 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:9/21/2017 12:49:40 PM PST]